Sunflower AS 33111

Optimized performance for short growing seasons

The AC 33111 sunflower hybrid by Aspria Seeds is engineered for growers who prioritize agility and high performance in intensive agricultural systems. Developed with the expertise of breeder Frederic Poujeaud, this hybrid offers significant flexibility with a growing period ranging from 90 to 110 days. This variability allows farms to schedule planting and harvesting windows effectively, mitigating the risks associated with unpredictable climate patterns.

Robust disease resistance

In modern sunflower farming, phytosanitary stability is the cornerstone of profit. AC 33111 stands out due to its genetic resistance profile, which effectively counters common threats that often devastate yields:

• Sclerotinia and Phomopsis: These prevalent threats are effectively managed at the genetic level.
• Phoma, Rust, and Powdery Mildew: The hybrid maintains plant integrity even under high humidity, protecting the photosynthetic area.
• Downy Mildew (Peronosporosis): Inherent resistance drastically reduces the reliance on early-stage fungicidal interventions, lowering input costs.

Economic value and agronomic traits

With an oil content ranging between 50% and 55%, AC 33111 is a high-value crop for processors, ensuring better marketability. The plant reaches a height of 160–170 cm, which is optimal for modern harvesting machinery, ensuring minimal harvest losses and even stand uniformity. Its structural stability ensures that the crop remains upright, protecting the yield until it reaches the silo.

Why choose AC 33111?

This hybrid is the ideal fit for farms looking to balance high-intensity output with reduced operational risk. Because it establishes quickly and manages water resources efficiently during the spring, it is well-suited for regions with variable precipitation. Whether you operate a large-scale enterprise or a specialized mid-sized farm, AC 33111 provides the reliability needed to ensure that high yields are not just a possibility, but a consistent outcome.